Evidence map›Paper›PMID 36360678›Full record

ArticleInternational journal of environmental research and public health2022

A Case Series of SARS-CoV-2 Reinfection in Elite Athletes.

Gábor Áron Fülöp, Bálint Lakatos, Mihály Ruppert, Attila Kovács, Vencel Juhász, Gábor Dér, András Tállay, Hajnalka Vágó, Boldizsár Kiss, Béla Merkely and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Gábor Áron FülöpThe Heart and Vascular Center, Semmelweis University, H-1122 Budapest, Hungary.
Bálint LakatosThe Heart and Vascular Center, Semmelweis University, H-1122 Budapest, Hungary.
Mihály RuppertThe Heart and Vascular Center, Semmelweis University, H-1122 Budapest, Hungary.
Attila KovácsThe Heart and Vascular Center, Semmelweis University, H-1122 Budapest, Hungary.ORCID 0000-0003-2320-6434
Vencel JuhászThe Heart and Vascular Center, Semmelweis University, H-1122 Budapest, Hungary.ORCID 0000-0001-9100-4952
Gábor DérThe Heart and Vascular Center, Semmelweis University, H-1122 Budapest, Hungary.
András TállayDepartment of Sports Medicine, Semmelweis University, H-1122 Budapest, Hungary.
Hajnalka VágóThe Heart and Vascular Center, Semmelweis University, H-1122 Budapest, Hungary.
Boldizsár KissThe Heart and Vascular Center, Semmelweis University, H-1122 Budapest, Hungary.ORCID 0000-0003-2059-5462
Béla MerkelyThe Heart and Vascular Center, Semmelweis University, H-1122 Budapest, Hungary.
Endre ZimaThe Heart and Vascular Center, Semmelweis University, H-1122 Budapest, Hungary.ORCID 0000-0001-5132-6009
Semmelweis University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe actual frequency and the risk factors of SARS-CoV-2 reinfection is still a matter of intense scientific discussion. In this case series, we report three elite athletes who underwent COVID-19 reinfection with a short time frame. CASE PRESENTATIONS: As a part of contact tracing, three speed skaters (22-, 24-, and 29-year-old males) were found to be SARS-CoV-2 positive by polymerase chain reaction (PCR) tests. Later on, only one of the athletes experienced mild symptoms, such as fatigue, loss of smell and taste and subfebrility, while the other two athletes were asymptomatic. Following the quarantine period, detailed return-to-play examinations, including laboratory testing, ECG, 24-h Holter monitoring, transthoracic echocardiography and cardiac magnetic resonance imaging, revealed no apparent abnormality; therefore, the athletes restarted training. After a median of 74 days, all three athletes presented with typical symptoms of COVID-19, such as fever, marked fatigue and headache. SARS-CoV-2 PCR tests were performed again, showing recurrent positivity. Repeated return-to-play assessments were initiated, finding no relevant abnormality. Athletes were also tested for SARS-CoV-2 anti-nucleoprotein antibody titers, showing only modest increases following the second infection.

conclusionsWe report a small cluster of elite athletes who underwent a PCR-proven SARS-CoV-2 reinfection. According to these findings, athletes may be considered as a high-risk group in terms of recurrent COVID-19.

Indexed as

COVID-19SARS-CoV-2AthletesFatigueHumansMaleReinfectionathletesCOVID-19reinfectionSARS-CoV-2

Identifiers

PMID36360678
PMCPMC9654332
OpenAlexW4307270743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.